CN Patent

CN113616616A — 一种利那洛肽胶囊制剂及其制备方法

Assigned to Sichuan Gowell Pharmaceutical Co ltd · Expires 2021-11-09 · 5y expired

What this patent protects

本发明提供一种长期储存稳定的利那洛肽胶囊制剂，通过控制制剂处方中微晶纤维素微丸中甲醛的含量＜1.0ppm，能明显降低利那洛肽胶囊长期储存过程中Cys 1 ‑IMD杂质的含量且不升高其他有关物质的含量，提供一种合格的利那洛肽胶囊制剂。

USPTO Abstract

本发明提供一种长期储存稳定的利那洛肽胶囊制剂，通过控制制剂处方中微晶纤维素微丸中甲醛的含量＜1.0ppm，能明显降低利那洛肽胶囊长期储存过程中Cys 1 ‑IMD杂质的含量且不升高其他有关物质的含量，提供一种合格的利那洛肽胶囊制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN113616616A
Jurisdiction
CN
Classification
—
Expires
2021-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Gowell Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.